Interestingly, UBR2 knock-down breast cancer cells are more sensitive to CICD than control cells, suggesting that overexpression of UBR2 in MDA-MB-231 cells could participate to the escape from CICD. This evidence concerns the gene UBR2 and breast carcinoma.